Gastroenterology

Latest News

patient talking to doctor |  Image credit: New Africa - stock.adobe.com
Clinical Evidence Shows No Safety Gaps Between Biosimilar, Reference Adalimumab

April 26th 2025

A plain language summary for patients explains there were no differences in safety outcomes between adalimumab-adbm and the originator in a pooled analysis of the VOLTAIRE clinical trials.

woman with inflammatory bowel disease | Image credit: eddows - stock.adobe.com
The Growing Impact of Biosimilars in IBD Care

April 23rd 2025

eye on pharma banner
Eye on Pharma: Sandoz Files Antitrust Suit; Yuflyma Interchangeability; Costco’s Ustekinumab Pick

April 22nd 2025

inflammatory bowel disease | Image credit: Panuwat D - stock.adobe.com
Biosimilar and Biologic Use Increasing in Greek Patients With IBD

April 19th 2025

biosimilar business deal | Image credit: Mongkolchon - stock.adobe.com
Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

April 14th 2025

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
cfb podcast banner
"When Choice Arrives: Competition & Consequences" written over a bright blue syringe with the AJMC/The Center for Biosimilars logo in the bottom right corner

More News

© 2025 MJH Life Sciences

All rights reserved.